What is AURX's dilution risk score?

AURX has a latest available DilutionScore record of 65/100, categorized as high dilution risk by the DilutionWatch scoring model. DilutionWatch displays SEC filing and dilution indicators for AURX, including shelf registrations, ATM offerings, warrant exercises, PIPE deals, and reverse split signals when detected in source data.

What SEC filings does DilutionWatch track for AURX?

DilutionWatch tracks 25 SEC filing types for AURX including S-3 shelf registrations, 424B prospectuses (ATM offerings), S-1 registration statements, 8-K material events, warrant exercise notices, convertible note agreements, and Form 4 insider transactions. Alerts are delivered via email within minutes of a filing appearing on EDGAR.

How does stock dilution affect AURX shareholders?

Stock dilution occurs when a company issues new shares, reducing the ownership percentage of existing shareholders. For AURX, common dilution events include at-the-market (ATM) stock offerings, shelf registration drawdowns, warrant exercises, and convertible note conversions. Each event increases the share count and can pressure the stock price lower.

Is DilutionWatch free for AURX tracking?

DilutionWatch provides a free tier that shows DilutionScores and basic filing history for AURX. Premium plans ($19.95/month Basic, $39.95/month Premium) unlock real-time email alerts, the full Pulse™ feed, advanced dilution forecasts, and access to all 10,000+ tracked tickers.

AURX Dilution Risk Score: 65/100 (component-limited)

Score Breakdown

📋 Offering Ability

40

💰 Cash Runway

95

📊Float Risk—

⚠️ Warrant Exposure

50

🔄 Convertible Debt

15

Dilution Forecast

🌥️

Advisory

Moderate dilution signals present

model est. 44%

💰 Capital Raise model 55%

• Critical: only 2.5 months cash remaining

🔄 Reverse Split model est. 45%

• 50-day avg $1.32 approaching $1 threshold

• Only 2 months cash — financial pressure

📜 Warrant Exercise model 15%

• Warrant overhang: 13.1% of shares outstanding

🔔 Track AURX — Get forecast alerts →

Market Data

Market Cap$47.92M

Shares Outstanding48.43M

FloatN/A

Cash$449.3K

DebtN/A

Short InterestN/A

Institutional Holdings

1 institutional holders · 4.7K shares

#1 Ancora Advisors LLC 4.7K shares

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest1.5K

Days to Cover1.0

% of FloatN/A

FINRA data as of Jul 31, 2026

Insider Buy/Sell Ratio

Recent SEC Activity

xbrl XBRL WARRANT 2025-12-31

xbrl XBRL CONVERTIBLE 2020-12-31

8-K 8K EVENT 2026-01-26

4 INSIDER TRANSACTION 2026-01-26

Full SEC filing analysis available with free account →

Recent News

No recent news

Factual AURX Dilution Snapshot

Nuo Therapeutics, Inc. (AURX) has a DilutionScore of 65/100, rated High dilution risk. Score date: August 28, 2026.

Stored outstanding warrants: 6.4M.
Recent SEC activity tracked for AURX: 8-K on 2026-01-26; 4 on 2026-01-26; xbrl on 2025-12-31.
Score coverage note: Float Risk is excluded because public-float data is unavailable.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

Related Stocks — HIGH Risk

Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,024+ tracked stocks →

📖 Dilution Education

→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations

Score Coverage Note

Float Risk is excluded because public-float data is unavailable.

AURX — Nuo Therapeutics, Inc. Dilution Risk Tracker